REGENXBIO (NASDAQ:RGNX – Free Report) had its price target raised by HC Wainwright from $36.00 to $38.00 in a research note published on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for REGENXBIO’s Q2 2024 earnings at ($1.27) EPS, Q3 2024 earnings […]
Nurix Therapeutics' (NRIX) Buy Rating Reaffirmed at Needham & Company LLC dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
GLOBALFOUNDRIES (NASDAQ:GFS) Now Covered by Jefferies Financial Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 23,440,000 shares, a growth of 16.5% from the April 15th total of 20,120,000 shares. Based on an average daily volume of 4,450,000 shares, […]
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) Director Gordon M. Binder acquired 50,000 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was acquired at an average cost of $6.78 per share, with a total value of $339,000.00. Following the transaction, the director now directly owns 160,000 shares of the […]